Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Silent thief of vision: many patients unaware of glaucoma risks

NCT ID NCT07153588

Knowledge-focused Sponsor: Bacha Khan Medical College Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study surveyed 379 eye clinic patients in Pakistan to find out how much they know about glaucoma, a disease that can cause blindness without early treatment. Participants answered a questionnaire about their eye history, knowledge of glaucoma, and beliefs about its curability. The results will help doctors create better awareness programs to encourage early eye screening.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help design better public education programs to catch glaucoma early and prevent vision loss.
What could go wrong
This is a small, single-center survey, not a treatment trial. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

379 people

The number who actually took part.

Started

Apr 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes adult patients aged 18 to 80 years who attend the Ophthalmology Outpatient Department (OPD) at Mardan Medical Complex, a tertiary care teaching hospital in Khyber Pakhtunkhwa, Pakistan. Both new and follow-up patients are included, regardless of whether they have glaucoma or another eye condition. Participants come from a variety of backgrounds, with many residing in rural areas and a large proportion having limited or no formal education. Patients with diagnosed glaucoma, those with other ocular problems such as cataract or refractive errors, and individuals with systemic conditions like diabetes or hypertension are all eligible. Patients unable to provide informed responses due to cognitive impairment, mental illness, ocular malignancy, or active ocular bleeding are excluded.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients between 18 and 80 years of age attending the Ophthalmology Outpatient Department (new or follow-up cases). * Patients with ocular conditions, including diagnosed glaucoma and other eye pathologies. Exclusion Criteria: * Patients with cognitive impairment or mental illness that limits their ability to understand or respond to the questionnaire. * Patients with ocular malignancy or active ocular bleeding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Glaucoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Glaucoma

Contacts and locations

Locations

  • Mardan Medical Comlex, Mardan

    Mardan, KPK, 23200, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.